Preferred Label : Osteogenesis imperfecta, type VIII;
Symbol : OI8;
CISMeF acronym : OI8;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Oi, type VIII;
Description : Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by bone
fragility and low bone mass. Due to considerable phenotypic variability, Sillence
et al. (1979) developed a classification of OI subtypes based on clinical features
and disease severity: OI type I, with blue sclerae (166200); perinatal lethal OI type
II, also known as congenital OI (166210); OI type III, a progressively deforming form
with normal sclerae (259420); and OI type IV, with normal sclerae (166220). Most forms
of OI are autosomal dominant with mutations in one of the 2 genes that code for type
I collagen alpha chains, COL1A1 (120150) and COL1A2 (120160). Cabral et al. (2007)
described a form of autosomal recessive OI, which they designated OI type VIII, characterized
by white sclerae, severe growth deficiency, extreme skeletal undermineralization,
and bulbous metaphyses.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the leucine- and proline-enriched proteoglycan 1 gene (LEPRE1,
610339.0001);
Laboratory abnormalities : Type 1 collagen overmodification; Absent-decreased prolyl 3-hydroxylation at collagen I alpha-1 pro986;
Prefixed ID : #610915;
Origin ID : 610915;
UMLS CUI : C1970458;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)